Zdrowie i gospodarka · 17/01/2006

FDA Releases Guidance for Industry on Exploratory Investigational New Drug Studies

The Food and Drug Administration (FDA) has made available a guidance document outlining key considerations for planning exploratory investigational new drug (IND) studies, including those involving closely related drugs or biologics.